Blood Cancer Discovery is the American Association for Cancer Research's journal, launched in 2020, for basic, translational and clinical research in leukaemia, lymphoma and myeloma. Authors pay publication charges and can pay extra to make articles open access; haematologists and cancer biologists working on blood cancers read it.
Blood Cancer Discovery was launched in 2020 by the American Association for Cancer Research (AACR) in Philadelphia. The AACR describes it as publishing high-quality Research Articles and Briefs representing major advances in basic, translational and clinical research of leukaemia, lymphoma, myeloma and associated diseases. Authors pay publication charges, and the AACR site refers separately to an Open Access fee, so articles can be made open access on payment; the journal is not listed in DOAJ. Members of the AACR's working group on blood cancers receive a discount on publication charges. Indexed in MEDLINE.
Shares PubMed & Europe PMC, Chronic lymphocytic leukaemia, Acute myeloid leukaemia, Multiple myeloma.
Shares PubMed & Europe PMC, Chronic lymphocytic leukaemia, Acute myeloid leukaemia, Multiple myeloma.
Shares PubMed & Europe PMC, Chronic lymphocytic leukaemia, Acute myeloid leukaemia, Multiple myeloma.
Shares PubMed & Europe PMC, Chronic lymphocytic leukaemia, Acute myeloid leukaemia.
Shares American Association for Cancer Research (AACR), PubMed & Europe PMC.
Shares American Association for Cancer Research (AACR), Acute myeloid leukaemia.
Shares American Association for Cancer Research (AACR), Acute myeloid leukaemia.